Abstract
Introduction Severe Acute Respiratory Syndrome Corona virus-2 (SARS-CoV-2) spread mainly through respiratory droplets and contact routes. Long term use of spectacles may prevent repeated touching and rubbing of the eyes. Aim of the study is to find out the protective effectiveness of the spectacles against COVID-19, if present.
Objectives To know the association between infection with SARSCoV-2 and wearing of spectacles.
Materials and methods In this study, 304 patients of Corona virus disease 2019 (COVID-19) were selected. Their spectacles wearing behaviour were assessed through a questionnaire. Spectacles wearing behaviour of general population were obtained from older studies (for comparison). Data was put in the tabulate form and Chi- Square test was used for statistical analysis.
Results In this study, among the 304 total patients, 58 patients showed the behavior of using spectacles continuously during day time and always on outdoor activities. While the spectacles wearing behaviour is about 40% among general Indian population. The protective effectiveness of the spectacles was found statistically significant (p-value. 00113).
Conclusion The present study showed that the occurrence of Covid-19 was less in spectacles wearing population than the population not wearing those. The nasolacrimal duct may be a route of virus transmission from conjunctival sac to the nasopharynx.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Nil
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Approved by ethical committee KV COVID Hospital, Department of Health, Kanpur Dehat.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Conflicts of interest- None of the authors have any proprietary interest related to this submission.
Financial support- Nil
Data Availability
Data available at record section KV COVID Hospital, Department of Health, Kanpur Dehat.
